Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms.

Elevated expression of the iron regulatory protein, ferritin heavy chain 1 (FTH1), is increasingly being associated with high tumor grade and poor survival outcomes in glioblastoma. Glioma initiating cells (GICs), a small population of stem-like cells implicated in therapeutic resistance and gliobla...

Full description

Bibliographic Details
Main Authors: Vagisha Ravi, Achuthamangalam B Madhankumar, Thomas Abraham, Becky Slagle-Webb, James R Connor
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0221952
_version_ 1818725872577806336
author Vagisha Ravi
Achuthamangalam B Madhankumar
Thomas Abraham
Becky Slagle-Webb
James R Connor
author_facet Vagisha Ravi
Achuthamangalam B Madhankumar
Thomas Abraham
Becky Slagle-Webb
James R Connor
author_sort Vagisha Ravi
collection DOAJ
description Elevated expression of the iron regulatory protein, ferritin heavy chain 1 (FTH1), is increasingly being associated with high tumor grade and poor survival outcomes in glioblastoma. Glioma initiating cells (GICs), a small population of stem-like cells implicated in therapeutic resistance and glioblastoma recurrence, have recently been shown to exhibit increased FTH1 expression. We previously demonstrated that FTH1 knockdown enhanced therapeutic sensitivity in an astrocytoma cell line. Therefore, in this study we developed a liposomal formulation to enable the in vitro delivery of FTH1 siRNA in patient xenograft derived GICs from glioblastomas with pro-neural and mesenchymal transcriptional signatures to interrogate the effect of FTH1 downregulation on their radiation sensitivity. Transfection with siRNA decreased FTH1 expression significantly in both GICs. However, there were inherent differences in transfectability between pro-neural and mesenchymal tumor derived GICs, leading us to modify siRNA: liposome ratios for comparable transfection. Moreover, loss of FTH1 expression resulted in increased extracellular lactate dehydrogenase activity, executioner caspase 3/7 induction, substantial mitochondrial damage, diminished mitochondrial mass and reduced cell viability. However, only GICs from pro-neural glioblastoma showed marked increase in radiosensitivity upon FTH1 downregulation demonstrated by decreased cell viability, impaired DNA repair and reduced colony formation subsequent to radiation. In addition, the stemness marker Nestin was downregulated upon FTH1 silencing only in GICs of pro-neural but not mesenchymal origin. Using liposomes as a siRNA delivery system, we established FTH1 as a critical factor for survival in both GIC subtypes as well as a regulator of radioresistance and stemness in pro-neural tumor derived GICs. Our study provides further evidence to support the role of FTH1 as a promising target in glioblastoma.
first_indexed 2024-12-17T21:49:13Z
format Article
id doaj.art-8ed939399d5e488e889c35212c2d1f6e
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-17T21:49:13Z
publishDate 2019-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-8ed939399d5e488e889c35212c2d1f6e2022-12-21T21:31:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01149e022195210.1371/journal.pone.0221952Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms.Vagisha RaviAchuthamangalam B MadhankumarThomas AbrahamBecky Slagle-WebbJames R ConnorElevated expression of the iron regulatory protein, ferritin heavy chain 1 (FTH1), is increasingly being associated with high tumor grade and poor survival outcomes in glioblastoma. Glioma initiating cells (GICs), a small population of stem-like cells implicated in therapeutic resistance and glioblastoma recurrence, have recently been shown to exhibit increased FTH1 expression. We previously demonstrated that FTH1 knockdown enhanced therapeutic sensitivity in an astrocytoma cell line. Therefore, in this study we developed a liposomal formulation to enable the in vitro delivery of FTH1 siRNA in patient xenograft derived GICs from glioblastomas with pro-neural and mesenchymal transcriptional signatures to interrogate the effect of FTH1 downregulation on their radiation sensitivity. Transfection with siRNA decreased FTH1 expression significantly in both GICs. However, there were inherent differences in transfectability between pro-neural and mesenchymal tumor derived GICs, leading us to modify siRNA: liposome ratios for comparable transfection. Moreover, loss of FTH1 expression resulted in increased extracellular lactate dehydrogenase activity, executioner caspase 3/7 induction, substantial mitochondrial damage, diminished mitochondrial mass and reduced cell viability. However, only GICs from pro-neural glioblastoma showed marked increase in radiosensitivity upon FTH1 downregulation demonstrated by decreased cell viability, impaired DNA repair and reduced colony formation subsequent to radiation. In addition, the stemness marker Nestin was downregulated upon FTH1 silencing only in GICs of pro-neural but not mesenchymal origin. Using liposomes as a siRNA delivery system, we established FTH1 as a critical factor for survival in both GIC subtypes as well as a regulator of radioresistance and stemness in pro-neural tumor derived GICs. Our study provides further evidence to support the role of FTH1 as a promising target in glioblastoma.https://doi.org/10.1371/journal.pone.0221952
spellingShingle Vagisha Ravi
Achuthamangalam B Madhankumar
Thomas Abraham
Becky Slagle-Webb
James R Connor
Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms.
PLoS ONE
title Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms.
title_full Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms.
title_fullStr Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms.
title_full_unstemmed Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms.
title_short Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms.
title_sort liposomal delivery of ferritin heavy chain 1 fth1 sirna in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms
url https://doi.org/10.1371/journal.pone.0221952
work_keys_str_mv AT vagisharavi liposomaldeliveryofferritinheavychain1fth1sirnainpatientxenograftderivedglioblastomainitiatingcellssuggestsdifferentsensitivitiestoradiationanddistinctsurvivalmechanisms
AT achuthamangalambmadhankumar liposomaldeliveryofferritinheavychain1fth1sirnainpatientxenograftderivedglioblastomainitiatingcellssuggestsdifferentsensitivitiestoradiationanddistinctsurvivalmechanisms
AT thomasabraham liposomaldeliveryofferritinheavychain1fth1sirnainpatientxenograftderivedglioblastomainitiatingcellssuggestsdifferentsensitivitiestoradiationanddistinctsurvivalmechanisms
AT beckyslaglewebb liposomaldeliveryofferritinheavychain1fth1sirnainpatientxenograftderivedglioblastomainitiatingcellssuggestsdifferentsensitivitiestoradiationanddistinctsurvivalmechanisms
AT jamesrconnor liposomaldeliveryofferritinheavychain1fth1sirnainpatientxenograftderivedglioblastomainitiatingcellssuggestsdifferentsensitivitiestoradiationanddistinctsurvivalmechanisms